688315.SH
Novogene Co., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 19.50
+15.80%Oct 21, 2026, 01:29 UTC
Novogene and Qijia Technology (Suzhou) Co., Ltd. signed a cooperation agreement to develop organoid multi-omics standards, pathology-model benchmarks, joint research projects and traditional Chinese medicine organoid evaluation standards.
Source:Sep 28, 2026, 13:27 UTC
Novogene Co., Ltd. saw two block trades totaling 1.40 million shares worth 27.874 million yuan on September 28, with one institutional seat net buying 13.937 million yuan.
Source:Aug 28, 2026, 10:09 UTC
Novogene announced it will build its first local laboratory in Australia in partnership with Cabrini Health, located at Cabrini Malvern's clinical and cancer research campus in Melbourne, expected to open in 2027.
Source:Aug 25, 2026, 09:23 UTC
Novogene Co., Ltd. announced its semi-annual results for 2026, reporting a net profit attributable to shareholders of 63.1226 million yuan, down 19.82% year-on-year.